Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction
| No. | 37 |
|---|---|
| Citation | Blood Adv 2(6),p715-730(2018) |
| Institute | University of Tübingen |
| 1st Author | O Borst |
| AR | ○ |
| PL | ○ |
| HD | |
| Paper types | Clinical investigations |
| Main purpose | Drug efficacy evaluation |
| Disease | ACS |
| Antiplatelet drug | Aspirin, Clopidogrel, Ticagrelor |
| Anticoagulant drug | Rivaroxaban |
| Other drug | |
| Clinical specimens | Patients receiving aspirin and Clopidogrel, Patients receiving aspirin and Ticagrelor |
| Animal | |
| Keyword |